オーストラリアの感染症検査市場動向(~2021)

【英語タイトル】Australia Infectious Diagnostics Market Outlook to 2021

GlobalDataが出版した調査資料(GDMECC1262DB)・商品コード:GDMECC1262DB
・発行会社(調査会社):GlobalData
・発行日:2015年10月1日
・ページ数:38
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:オーストラリア
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Australia Infectious Diagnostics Market Outlook to 2021

Summary

GlobalData’s new report, “Australia Infectious Diagnostics Market Outlook to 2021″, provides key market data on the Australia Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments – Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the Australia Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Infectious Diagnostics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Infectious Diagnostics Market, Australia 8
3.1 Infectious Diagnostics Market, Australia, Revenue ($m), 2007-2014 8
3.2 Infectious Diagnostics Market, Australia, Revenue ($m), 2014-2021 10
3.2.1 Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2007-2014 12
3.2.2 Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2014-2021 14
3.3 Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), 2013-2014 16
3.4 Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), 2014 17
4 Overview of Key Companies in Australia, Infectious Diagnostics Market 19
4.1 Abbott Laboratories 19
4.1.1 Company Overview 19
4.2 Siemens Healthcare 19
4.2.1 Company Overview 19
4.3 F. Hoffmann-La Roche Ltd. 19
4.3.1 Company Overview 19
4.4 Qiagen N.V. 20
4.4.1 Company Overview 20
4.5 Danaher Corporation 20
4.5.1 Company Overview 20
4.6 bioMerieux S.A. 20
4.6.1 Company Overview 20
4.7 Bio-Rad Laboratories, Inc. 21
4.7.1 Company Overview 21
4.8 Becton, Dickinson and Company 21
4.8.1 Company Overview 21
5 Infectious Diagnostics Market Pipeline Products 22
6 Financial Deals Landscape 34
6.1 Partnerships 34
6.1.1 Biocartis Enters into Licensing and Development Agreement with Microbiome 34
7 Appendix 35
7.1 Research Methodology 36
7.1.1 Coverage 36
7.1.2 Secondary Research 36
7.1.3 Primary Research 36
7.1.4 Company Share Analysis 37
7.1.5 Distribution Share Analysis 37
7.2 GlobalData Consulting 37
7.3 Contact Us 37
7.4 Disclaimer 38

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 9
Table 2: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Table 3: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 13
Table 4: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Table 5: Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 16
Table 6: Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 18
Table 7: Infectious Diagnostics Market Pipeline Products 22
Table 8: Biocartis Enters into Licensing and Development Agreement with Microbiome 34

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 8
Figure 2: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Figure 3: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 12
Figure 4: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Figure 5: Infectious Diagnostics Market, Australia, Company Share (%) 2014 17

【掲載企業】

Abbott Laboratories
Siemens Healthcare
F. Hoffmann-La Roche Ltd.
Qiagen N.V.
Danaher Corporation
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company

★調査レポート[オーストラリアの感染症検査市場動向(~2021)] (コード:GDMECC1262DB)販売に関する免責事項を必ずご確認ください。
★調査レポート[オーストラリアの感染症検査市場動向(~2021)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆